Dialysis world news


Docs warn on rising kidney patient figures - Hong Kong Standard PDF Print
Hong Kong Standard
A total of 7372 people needed dialysis or a kidney transplant last year, according to the Hospital Authority. But Philip Li Kam-tao, head of nephrology and honorary professor at Chinese University, said: "Only seven Hongkongers in a million are willing

...

 
St. Joseph's Children's Hospital Opens New Subspecialty Center In Hoboken - ParamusPost.com PDF Print
ParamusPost.com
The expanding pediatric subspecialty services at the Hoboken center currently include Pulmonology, Allergy/Immunology, Endocrinology, Nephrology, Hematology/Oncology and Gastroenterology. St. Joseph's Children's Hospital at St. Joseph's Regional

...

 
FDA Panel Votes in Favor of Renal Cell Carcinoma Drug - MedPage Today PDF Print
MedPage Today
The vote came after several hours of discussion about Pfizer's 723-patient trial, which showed that renal cell carcinoma patients who had previously received sunitinib treatment for their advanced renal cancer (a group that includes most patients with ...
FDA Advisory Committee Finds The Benefit/Risk Profile Of Axitinib In

...

 
Bearish Moving Average Cross by NxStage Medical (NXTM) - Financial News Network Online PDF Print
Financial News Network Online
NxStage Medical, Inc. is medical device company that develops, manufactures, and markets systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. The Company's primary product, the NxStage System One, is a small,

...

 
Implications of biosimilars in clinical practice tackled - Philippine Star PDF Print
Philippine Star
MANILA, Philippines - Pharmaceutical company Roche recently conducted a medical symposium where it invited doctors from various specialties such as medical oncology, rheumatology, endocrinology, gastroenterology, and nephrology for a scientific meeting

...

 
<< Start < Prev 571 572 573 574 575 576 577 578 579 580 Next > End >>

Page 577 of 2630
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.